Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Author Archives: PharmAust

Phase II Strategy Update

News & Announcements 2016By PharmAustNovember 21, 2016

161121_Phase II Strategy Update

Results of annual general meetings

Financial Reports 2016, News & Announcements 2016By PharmAustNovember 11, 2016

161111_RESULTS OF ANNUAL GENERAL MEETING

Appendix 3B

Financial Reports 2016, News & Announcements 2016By PharmAustNovember 11, 2016

161108_Appendix 3B

Notice of annual general meeting and explanatory statement

Financial Reports 2016, News & Announcements 2016By PharmAustNovember 11, 2016

161011_NOTICE OF ANNUAL GENERAL MEETING AND EXPLANATORY STATEMENT

PharmAust Limited (ASX – PAA) Secondary trading notice

News & Announcements 2016By PharmAustNovember 10, 2016

170103_PHARMAUST LIMITED (ASX- PAA) – SECONDARY TRADING NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001

PharmAust AGM presentation

Investor Presentations 2016, News & Announcements 2016By PharmAustNovember 10, 2016

161111_PharmAust AGM presentation

Non renounceable rights offer

News & Announcements 2016By PharmAustNovember 7, 2016

161108_Non renounceable rights offer

Prospectus

News & Announcements 2016By PharmAustNovember 1, 2016

Appendix 4C – Quarterly Report & Company Update for the period ended 30 September 2016

Financial Reports 2016, News & Announcements 2016By PharmAustOctober 31, 2016

161031_Appendix 4C – Quarterly Report & Company Update for the period ended 30 September 2016

Second canine receives treatment in trial

News & Announcements 2016By PharmAustOctober 14, 2016

161014_SECOND CANINE RECEIVES TREATMENT IN TRIAL

1
23456789
…1011121314…
151617181920
21
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on TwitterPharmAust Retweeted
epichemEpichem@epichem·
29 Jun

𝐖𝐄𝐋𝐂𝐎𝐌𝐄 Fiona Milner!

Today we are rolling out the red carpet as Fiona Milner joins Epichem Pty Ltd as General Manager. The Epichem team are thrilled to have Fiona on board and we look forward to working with her.

#teamepichem

Reply on Twitter 1541992242344333312Retweet on Twitter 15419922423443333121Like on Twitter 15419922423443333125Twitter 1541992242344333312
Load More...
Copyright © 2020 Pharmaust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top